Aiosyn
Aiosyn is revolutionizing precision pathology with AI-powered software solutions that enhance patient outcomes in breast cancer and kidney disease.
Located in the Netherlands, Aiosyn leverages over two decades of research experience in pathology to develop advanced precision pathology software. The company's solutions are seamlessly integrated into standard pathology workflows, focusing on breast cancer and kidney disease.
Aiosyn is dedicated to transforming the field of precision pathology through the application of artificial intelligence. By incorporating deep-learning algorithms into existing workflows, Aiosyn's software provides data-driven insights that significantly improve patient outcomes.
The company's AI-driven technology is designed to offer new perspectives for pathology labs and biopharma companies, helping them discover the most effective treatments while optimizing workflow efficiency.
